The Technology Transfer Office (TTO) was established to facilitate the commercialization of the University's scientific and technical research findings for the benefit of the citizens of Ohio and the general public through the efficient evaluation, management, and licensing of the University's intellectual property including patents, copyrights and trademarks.
Invention Disclosure Pipeline
The CSU Patent Review Committee has approved the invention disclosure of Dr. Moo-Yeal Lee, an associate professor in the Department of Chemical and Biomedical Engineering (CBE), titled Perfusion Well Plate for Miniature 3D Bioprinting. The innovative design improves cell imaging capabilities and supports tissue-tissue interactions within the device structure, which will lead to improvements in the investigation of complex organ-organ communications for disease modeling and predictive drug screening.
TeCK Fund Phase II Awarded
The TeCK Fund, a joint technology commercialization and startup fund co-managed by Cleveland State University and Kent State University, has been awarded $300,000 by the Ohio Third Frontier Commission to continue its mission to accelerate commercialization of university technology and bring innovative new products to market. The funding augments a previous combined award of $800,000 that established the TeCK Fund in 2017. The TeCK Fund provides faculty pursuing applied research projects with funding to assist with commercialization activities, including prototype creation, third-party validation, and market research, which are required to successfully spin off technologies.
Research developed at Cleveland State University often has applications as products or services outside the boundaries of the University. Through its efforts, the TTO endeavors to inspire and nurture a culture of innovation at CSU with the ultimate goal of creating new technologies that improve society, lead to more job creation, and more revenue for the inventors, the University and the State of Ohio.
Please contact us with any questions or inquries you may have.